scholarly article | Q13442814 |
P356 | DOI | 10.1002/HEP.510230315 |
P698 | PubMed publication ID | 8617430 |
P2093 | author name string | Kunkel SL | |
Strieter RM | |||
Burdick MD | |||
Walz A | |||
Colletti LM | |||
Kunkel RG | |||
Wilke CA | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 506-514 | |
P577 | publication date | 1996-03-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat | |
P478 | volume | 23 |
Q33759955 | 15-Deoxy-Δ12,14-prostaglandin J2 alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy |
Q41824288 | 7,8-dihydroxycoumarin has a dual mechanism of action in hepatic ischemia reperfusion injury |
Q52851254 | A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury. |
Q47675507 | Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells |
Q34480193 | Analysis of polyunsaturated fatty acids and the omega-6 inflammatory pathway in hepatic ischemia/re-perfusion injury |
Q46128373 | Anti-inflammatory effect of lycopene on carrageenan-induced paw oedema and hepatic ischaemia-reperfusion in the rat. |
Q55074125 | Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury. |
Q41671209 | Antioxidant Stress and Anti-Inflammation of PPARα on Warm Hepatic Ischemia-Reperfusion Injury |
Q73388092 | Attenuation of Leukocyte Adhesion by Recombinant TNF-Binding Protein After Hemorrhagic Shock in the Rat |
Q41738693 | Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant |
Q44637695 | Bile secretory function after warm hepatic ischemia-reperfusion injury in the rat |
Q34422178 | Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice. |
Q41983341 | CD44 disruption attenuates murine hepatic ischemia/reperfusion injury |
Q37589136 | CXC chemokines play a critical role in liver injury, recovery, and regeneration |
Q35840590 | CXC-chemokine regulation and neutrophil trafficking in hepatic ischemia-reperfusion injury in P-selectin/ICAM-1 deficient mice |
Q40657165 | Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats |
Q48246398 | Chemokine Involvement in Lung Injury Secondary to Ischaemia/Reperfusion |
Q74172331 | Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells |
Q34605411 | Chemokines as novel therapeutic targets in inflammatory diseases |
Q35980338 | Chemokines in acute respiratory distress syndrome |
Q83984819 | Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury |
Q35062521 | Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers |
Q84425739 | Cytokine balance in hepatosplanchnic system during thoracoabdominal aortic aneurysm repair |
Q41695652 | Cytokines and the liver |
Q44224838 | Cytotoxic response of sinusoidal endothelial cells to polymorphonuclear leukocytes and its potential implication in hypoxia-reoxygenation injury |
Q35771439 | Decreased apoptosis in fatty livers submitted to subnormothermic machine-perfusion respect to cold storage. |
Q45868935 | Differential Chemokine and Chemokine Receptor Gene Induction by Ischemia, Alloantigen, and Gene Transfer in Cardiac Grafts |
Q44462385 | Differential nitric oxide synthase expression during hepatic ischemia-reperfusion |
Q37316491 | Does living donor hyperoxia have an impact on kidney graft function after transplantation? |
Q91900107 | Downregulating Serine Hydroxymethyltransferase 2 Deteriorates Hepatic Ischemia-Reperfusion Injury through ROS/JNK/P53 Signaling in Mice |
Q41764934 | Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. |
Q78053149 | Effect of graded hypoxia on hepatic tissue oxygenation measured by near infrared spectroscopy |
Q39176567 | Effect of infliximab on acute hepatic ischemia/reperfusion injury in rats |
Q56558843 | Effect of preischemic treatment with fenofibrate, a peroxisome proliferator-activated receptor-α ligand, on hepatic ischemia-reperfusion injury in rats |
Q84974197 | Evaluation of early macrophage activation and NF-kappaB activity in pulmonary injury caused by deep hypothermia circulatory arrest: an experimental study |
Q38352945 | Ex vivo transfer of nuclear factor-kappaB decoy ameliorates hepatic cold ischemia/reperfusion injury |
Q36743874 | Factors in the pathophysiology of the liver ischemia-reperfusion injury |
Q33734501 | Gene therapy in transplantation |
Q83695948 | HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat |
Q36229208 | HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling |
Q27323910 | Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes |
Q38176371 | Hepatic ischemia and reperfusion injury and trauma: current concepts |
Q34292863 | Hepatic ischemia-reperfusion injury |
Q64127379 | Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients |
Q73625256 | Hepatic stellate cells reversibly express alpha-smooth muscle actin during acute hepatic ischemia |
Q34147508 | Hepatocyte Death: A Clear and Present Danger |
Q39721640 | Hyperbaric oxygen therapy and liver transplantation. |
Q44967754 | Hypertonic preconditioning prevents hepatocellular injury following ischemia/reperfusion in mice: a role for interleukin 10. |
Q36441318 | IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation |
Q73520225 | In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment |
Q39294134 | Incidence and risk factors for early renal dysfunction after liver transplantation |
Q39319182 | Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer |
Q54238883 | Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κB dependent pathway. |
Q39065726 | Inhibition of neutral sphingomyelinase decreases arachidonic acid mediated inflammation in liver ischemia-reperfusion injury |
Q38881369 | Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia-reperfusion injury. |
Q48003498 | Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice |
Q73685289 | Interleukin-6 release in the hepatic blood outflow during normothermic liver ischaemia in humans |
Q54765273 | Intermittent hepatic ischemia-reperfusion minimizes liver metastasis in rats. |
Q49592640 | Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in Mice |
Q41868871 | Ischaemia and reperfusion injury of rat liver increases expression of glutathione S-transferase A1/A2 in zone 3 of the hepatic lobule |
Q46843961 | Ischemic preconditioning and intermittent clamping increase the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. |
Q36672281 | JunD protects the liver from ischemia/reperfusion injury by dampening AP-1 transcriptional activation |
Q73187459 | Matrix metalloproteinase inhibition protects hepatic integrity in hemorrhagic shock |
Q34683345 | Neutrophil-mediated tissue injury in alcoholic hepatitis |
Q50047875 | Neutrophils: a cornerstone of liver ischemia and reperfusion injury |
Q33433206 | No evidence for protective erythropoietin alpha signalling in rat hepatocytes |
Q28579337 | Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion |
Q73074279 | P-selectin and chemokine response after liver ischemia and reperfusion |
Q77220681 | Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury |
Q50215549 | Pentoxifylline enhances the protective effects of hypertonic saline solution on liver ischemia reperfusion injury through inhibition of oxidative stress. |
Q46963763 | Preconditioning-like amelioration of erythropoietin against laparoscopy-induced oxidative injury |
Q47876999 | Prevention of reoxygenation injury by sodium salicylate in isolated-perfused rat liver |
Q43728803 | Protection against liver ischemia-reperfusion injury in rats by silymarin or verapamil |
Q25257279 | Protection of early phase hepatic ischemia-reperfusion injury by cholinergic agonists |
Q34636645 | Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb |
Q44533652 | Rat liver ischemia-reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment |
Q73782198 | Regulation of the C-X-C chemokine, mob-1, gene expression in primary rat hepatocytes |
Q43073089 | Role of P-selectin and anti-P-selectin monoclonal antibody in apoptosis during hepatic/renal ischemia reperfusion injury |
Q34548320 | Role of chemokines and chemokine receptors in the gastrointestinal tract |
Q37823547 | Role of nitric oxide in hepatic ischemia-reperfusion injury |
Q34429471 | Senegenin attenuates hepatic ischemia-reperfusion induced cognitive dysfunction by increasing hippocampal NR2B expression in rats |
Q35574175 | Sex differences in inflammatory cytokine production in hepatic ischemia-reperfusion |
Q44404898 | Systemic nf-κB activation in a transgenic mouse model of acute pancreatitis |
Q44934179 | Tempol, an intracelullar free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. |
Q71929585 | The MAP kinase cascades are activated during post-ischemic liver reperfusion |
Q58726261 | The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD) |
Q50522041 | The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver. |
Q36403403 | The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion |
Q41849723 | The protective effect of erythropoietin on ischaemia/reperfusion injury of liver |
Q73401724 | The ratio of ELR+ to ELR- CXC chemokines affects the lung and liver injury following hepatic ischemia/ reperfusion in the rat |
Q23919498 | The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride |
Q79449893 | Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat |
Q35192812 | Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling |
Q50507607 | Topical hepatic hypothermia attenuates pulmonary injury after hepatic ischemia and reperfusion. |
Q43086096 | Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury |
Q77598606 | Xanthine oxidase inhibition attenuates kupffer cell production of neutrophil chemoattractant following ischemia-reperfusion in rat liver |
Q44587928 | [D-Ala2, D-Leu5] enkephalin (DADLE) protects liver against ischemia-reperfusion injury in the rat. |
Search more.